Efficacy of a Single Administration of 5% Povidone-Iodine in the Treatment of Adenoviral Conjunctivitis
American Journal of Ophthalmology(2021)
摘要
•5% povidone-iodine appears safe and well tolerated by patients with adenoviral conjunctivitis.•5% povidone-iodine could reduce adenoviral load if individuals present ≤4 days of symptom onset.•5% povidone-iodine could hasten resolution of signs and symptoms of adenoviral conjunctivitis.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要